Please try another search
For the three months ended 31 March 2021, AuriniaPharmaceuticals Inc revenues totaled $914K. Net losstotaled to $50.4M. Results are not comparable due to GAAPchange.
Period Ending: | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 |
---|---|---|---|---|
Total Revenue | 0.91 | 50.12 | 0.03 | 0.03 |
Gross Profit | 0.87 | -0.27 | 0.13 | |
Operating Income | -50.54 | -104.29 | -36.99 | -27.25 |
Net Income | -50.38 | -102.68 | -34.06 | -29.53 |
Period Ending: | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 |
---|---|---|---|---|
Total Assets | 417.08 | 463.66 | 461.75 | 295.28 |
Total Liabilities | 46.85 | 55.91 | 62.91 | 56.24 |
Total Equity | 370.23 | 407.75 | 398.84 | 239.04 |
Period Ending: | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 |
---|---|---|---|---|
Period Length: | 3 Months | 12 Months | 9 Months | 6 Months |
Cash From Operating Activities | -53.54 | -69.86 | -75.31 | -45.31 |
Cash From Investing Activities | -67.25 | -158.19 | -175.08 | -32.17 |
Cash From Financing Activities | 5.03 | 194.38 | 193.13 | 3.88 |
Net Change in Cash | -115.76 | -33.67 | -57.26 | -73.61 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review